Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sustained hematologic remission after discontinuation of sutimlimab treatment in patients with cold agglutinin disease. | Blood Adv | 2023 | 36322823 | PubTator, text mining | PubMed |
| Chronic cold agglutinin disease after a third COVID-19 mRNA vaccination. | Int J Hematol | 2023 | 36309629 | PubTator, text mining | PubMed |
| ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura. | Blood Adv | 2023 | 36306339 | PubTator, text mining | PubMed |
| Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease. | Annu Rev Pathol | 2023 | 36270295 | PubTator, text mining | PubMed |
| Therapeutic regulation of complement activation in extracorporeal circuits and intravascular treatments with special reference to the alternative pathway amplification loop. | Immunol Rev | 2023 | 36258635 | PubTator, text mining | PubMed |
| Low-molecular weight inhibitors of the alternative complement pathway. | Immunol Rev | 2023 | 36217774 | PubTator, text mining | PubMed |
| Consensus statement on heart xenotransplantation in children: Toward clinical translation. | J Thorac Cardiovasc Surg | 2023 | 36184321 | PubTator, text mining | PubMed |
| Intracellular complement: Evidence, definitions, controversies, and solutions. | Immunol Rev | 2023 | 36100972 | PubTator, text mining | PubMed |
| Vascular surgery patients with elevated neutrophil-to-lymphocyte ratios have downregulated neutrophil complement RNA expression. | Blood Adv | 2023 | 36006440 | PubTator, text mining | PubMed |
| Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease. | Dig Dis Sci | 2023 | 35989383 | PubTator, text mining | PubMed |
| Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia. | Blood Adv | 2023 | 35973190 | PubTator, text mining | PubMed |
| Complement activation in COVID-19 and targeted therapeutic options: A scoping review. | Blood Rev | 2023 | 35934552 | PubTator, text mining | PubMed |
| Liver vs. spleen: Time course of organ-dependent immune gene expression in an LPS-stimulated toad (Rhinella diptycha). | Comp Biochem Physiol B Biochem Mol Biol | 2023 | 35931313 | PubTator, text mining | PubMed |
| Familial acute aortic dissection associated with a novel ACTA2 germline variant. | Virchows Arch | 2023 | 35896809 | PubTator, text mining | PubMed |
| Screening of Diabetic Nephropathy Progression-Related Genes Based on Weighted Gene Co-expression Network Analysis. | Biochem Genet | 2023 | 35834115 | PubTator, text mining | PubMed |
| Lectin Pathway Enzyme MASP-2 and Downstream Complement Activation in COVID-19. | J Innate Immun | 2023 | 35816998 | PubTator, text mining | PubMed |
| Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. | Rheumatology (Oxford) | 2023 | 35532072 | PubTator, text mining | PubMed |
| Nearly 70 years later: the continued unraveling of Castleman disease. | Haematologica | 2023 | 35484683 | PubTator, text mining | PubMed |
| The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease. | Haematologica | 2023 | 35484648 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=25